Cell Lysis and Disruption Market Forecast to 2028 - Covid-19 Impact and Global Analysis - By Product ( Instruments, Reagents and Kits, Enzymes, Consumables ); Technique ( Reagent-Based, Physical Disruption ); Cell Type ( Mammalian Cells, Bacterial Cells, Microbial Cells (Yeast/Algae/Fungi), Plant Cells ); Application ( Protein Isolation, Downstream Processing, Cell Organelle Isolation, Nucleic Acid Isolation ); End User ( Academic and Research Institutes, Hospitals and Diagnostic Labs, Cell Banks, Pharmaceutical and Biotechnology Companies ) and Geography
Report Code: TIPRE00006861 No. of Pages: 150 Category: Biotechnology Status: Upcoming
Assesing the covid-19 impact?
Get the Latest COVID-19 Analysis on this market
Request Now
Request Now
Happy to join you in your fight against the COVID-19 economic pandemic!
MARKET INTRODUCTION
Cell lysis refers to breaking down of the cells by viral, osmotic or enzymatic mechanisms which helps to compromise the integrity of the cells. The technique is majorly incorporated to degrade or denature sensitive proteins and DNA often used in western and southern blotting for the analysis of lipids, proteins and other biomolecules. On the other hand, cell disruption is the process that involves break-opening the cell membrane and walls to obtain intracellular fluids.
MARKET DYNAMICS
The cell lysis and disruption market is anticipated to grow in the forecast period owing to driving factors such as technological development in the field of biotechnology, expanding biotechnology and biopharmaceutical industries and increasing focus towards personalized medicines. On the other hand, shortage of skilled personnel and high implementation costs are expected to negatively impact the market growth.
MARKET SCOPE
The "Global Cell Lysis and Disruption Market Analysis to 2028" is a specialized and in-depth study of the medical device industry with a special focus on the global market trend analysis. The report aims to provide an overview of cell lysis and disruption market with detailed market segmentation by product, technique, cell type, application, end user, and geography. The global cell lysis and disruption market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading cell lysis and disruption market players and offers key trends and opportunities in the market.
MARKET SEGMENTATION
The global cell lysis and disruption market is segmented on the basis of product, technique, cell type, application, and end user. Based on product, the market is segmented into instruments, reagents and kits, enzymes, and consumables. Based on technique, the market is segmented into reagent-based, and physical disruption. On the basis of cell type, the market is segmented into mammalian cells, bacterial cells, microbial cells, and plant cells. The market on the basis of application is segmented into protein isolation, downstream processing, cell organelle isolation, and nucleic acid isolation. Based on end user, the market is segmented into academic and research institutes, hospitals and diagnostic labs, cell banks, and pharmaceutical and biotechnology companies.
The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the global cell lysis and disruption market based on various segments. It also provides market size and forecast estimates from year 2020 to 2028 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The cell lysis and disruption market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.
The report analyzes factors affecting cell lysis and disruption market from both demand and supply side and further evaluates market dynamics effecting the market during the forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the cell lysis and disruption market in these regions.
The reports cover key developments in the cell lysis and disruption market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies activities witnessed in the market were acquisitions, and partnership & collaborations. These activities have paved way for expansion of business and customer base of market players. The market payers from cell lysis and disruption market are anticipated to lucrative growth opportunities in the future with the rising demand for cell lysis and disruption market in the global market. Below mentioned is the list of few companies engaged in the cell lysis and disruption market.
The report also includes the profiles of key cell lysis and disruption market companies along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, components and services offered, financial information of last 3 years, key development in past five years.
Cell lysis refers to breaking down of the cells by viral, osmotic or enzymatic mechanisms which helps to compromise the integrity of the cells. The technique is majorly incorporated to degrade or denature sensitive proteins and DNA often used in western and southern blotting for the analysis of lipids, proteins and other biomolecules. On the other hand, cell disruption is the process that involves break-opening the cell membrane and walls to obtain intracellular fluids.
MARKET DYNAMICS
The cell lysis and disruption market is anticipated to grow in the forecast period owing to driving factors such as technological development in the field of biotechnology, expanding biotechnology and biopharmaceutical industries and increasing focus towards personalized medicines. On the other hand, shortage of skilled personnel and high implementation costs are expected to negatively impact the market growth.
MARKET SCOPE
The "Global Cell Lysis and Disruption Market Analysis to 2028" is a specialized and in-depth study of the medical device industry with a special focus on the global market trend analysis. The report aims to provide an overview of cell lysis and disruption market with detailed market segmentation by product, technique, cell type, application, end user, and geography. The global cell lysis and disruption market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading cell lysis and disruption market players and offers key trends and opportunities in the market.
MARKET SEGMENTATION
The global cell lysis and disruption market is segmented on the basis of product, technique, cell type, application, and end user. Based on product, the market is segmented into instruments, reagents and kits, enzymes, and consumables. Based on technique, the market is segmented into reagent-based, and physical disruption. On the basis of cell type, the market is segmented into mammalian cells, bacterial cells, microbial cells, and plant cells. The market on the basis of application is segmented into protein isolation, downstream processing, cell organelle isolation, and nucleic acid isolation. Based on end user, the market is segmented into academic and research institutes, hospitals and diagnostic labs, cell banks, and pharmaceutical and biotechnology companies.
The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the global cell lysis and disruption market based on various segments. It also provides market size and forecast estimates from year 2020 to 2028 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The cell lysis and disruption market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.
The report analyzes factors affecting cell lysis and disruption market from both demand and supply side and further evaluates market dynamics effecting the market during the forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the cell lysis and disruption market in these regions.
The reports cover key developments in the cell lysis and disruption market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies activities witnessed in the market were acquisitions, and partnership & collaborations. These activities have paved way for expansion of business and customer base of market players. The market payers from cell lysis and disruption market are anticipated to lucrative growth opportunities in the future with the rising demand for cell lysis and disruption market in the global market. Below mentioned is the list of few companies engaged in the cell lysis and disruption market.
The report also includes the profiles of key cell lysis and disruption market companies along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, components and services offered, financial information of last 3 years, key development in past five years.
- Thermo Fisher Scientific Inc.
- Merck KGaA
- F. Hoffmann-La Roche Ltd
- Qiagen NV
- BD
- Danaher
- Bio-Rad Laboratories, Inc.
- Miltenyi Biotec GmbH
- Claremont BioSolutions, LLC.
- Microfluidics International Corporation